Official SEC submissions

Lakewood-Amedex Biotherapeutics SEC Filings

Lakewood-Amedex Biotherapeutics (LABT) SEC filings, periodic reports and inside…

Direct answer

Lakewood-Amedex Biotherapeutics's latest SEC filing is 10-Q.

It was filed on August 14, 2026, and 15 recent filings are available.
Each row links directly to the SEC document and filing index.

Get free Lakewood-Amedex Biotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

10-Q

Periodic report

Filed:

Report date:

QUARTERLY REPORT

DEFA14A

Proxy statement

Filed:

DEFINITIVE ADDITIONAL MATERIALS

DEF 14A

Proxy statement

Filed:

Report date:

PROXY STATEMENT

8-K

Current report

Filed:

Report date:

CURRENT REPORT

8-K

Current report

Filed:

Report date:

CURRENT REPORT

10-Q

Periodic report

Filed:

Report date:

QUARTERLY REPORT

4

Insider transaction

Filed:

Report date:

4

S-1

Registration statement

Filed:

REGISTRATION STATEMENT

8-K

Current report

Filed:

Report date:

CURRENT REPORT

S-1/A

Registration statement

Filed:

REGISTRATION STATEMENT

S-1/A

Registration statement

Filed:

REGISTRATION STATEMENT

S-1/A

Registration statement

Filed:

REGISTRATION STATEMENT

S-1/A

Registration statement

Filed:

REGISTRATION STATEMENT

S-1/A

Registration statement

Filed:

REGISTRATION STATEMENT

S-1

Registration statement

Filed:

REGISTRATION STATEMENT

Verified data

Recent filing categories
5
Recent filings
15
SEC CIK
0002079272
Latest filing date
August 14, 2026